Costa, Dr Alessandro alessandro.costa**[ta]**ck.ac.uk
Architecture and Dynamics of Macromolecular Machines The Francis Crick Institute 01/03/2012
Cosway, Dr Benjamin benjamin.cosway**[ta]**.ac.uk
Harnessing Autophagy For the Clinical Beneft of Oropharyngeal Squamous
Crabb, Dr Simon S.J.Crabb**[ta]**thampton.ac.uk
CRUKE/12/023: (SAKK08/11) Orteronel maintenance therapy in patients with metastatic castration resistant prostate cancer and non-progressive disease after frst-line docetaxel therapy: A multicenter randomized double-blind placebo-controlled phase III trial University of Southampton 01/11/2012
CRUK/12/042: A phase I/randomised phase II study in metastatic castration resistant Prostate Cancer of AZD
CRUKD/16/004 SPIRE: A Phase Ib/IIa clinical trial combining DNA Methyltransferase inhibitor SGI110 with cisplatin and gemcitabine chemotherapy in patients with advanced solid tumours including bladder
Cree, Professor Ian ian.cree**[ta]**w.nhs.uk
Systematic reviews to underpin the development of a blood test for cancer University of Warwick 01/02/2014
The above is a list of Cancer Research
CRUK/11/058: Neo-SCOPE: Neo-adjuvant Study of Chemoradiotherapy in OesoPhageal Cancer Velindre NHS Trust 01/01/2012
CRUK/14/022: SCOPE2 - A randomised Phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with defnitive chemoradiation with an embedded Phase II trial for patients with a poor early response using positron emission tomography (PET) Velindre NHS Trust 01/01/2015
Cunningham, Professor David david.cunningham**[ta]**.nhs.uk
CRUKE/11/020: CHEMO-T: CHOP verses GEM-P in the frst line treatment Of T-cell Lymphoma Royal Marsden NHS Foundation Trust 01/10/2011
CRUK/06/025: ST03: A randomised phase II/ III study of peri-operative chemotherapy with or without bevacizumab in patients with operable adenocarcinoma of the stomach and gastrooesophageal
Cuzick, Professor Jack j.cuzick**[ta]**l.ac.uk
CRUK/04/032 AND CRUK/04/033: IBIS II Queen Mary, University of London 01/04/2004
Cancer Prevention Queen Mary,
Cvejic, Dr Ana as889**[ta]**.ac.uk
Closing the knowledge gap in post-genomic research: Fast-track functional characterisation of genes implicated in human blood formation and pathologies using zebrafsh as an in vivo model.University of Cambridge 01/10/2012
Cwynarski, Dr Kate kate.cwynarski**[ta]**.net CRUK/10/023: IESLG-32: Randomised Phase II Trial on primary CT with Methotrexate & Cytarabine +/- Thiotepa & Rituximab, followed by brain irradiation vs.high-dose CT supported by ASCT for immunocompetent patients with CNS lymphom University of Southampton 01/02/2011
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.CRUK/14/044 IELSG 42: International phase II trial assessing tolerability and efcacy of sequential MTX/ Ara-C-based regimen and R-ICE, followed by high dose chemotherapy supported by PBSCT, in patients with systemic B-cell lymphoma with central nervous system involvement at diagnosis or relapse University of Southampton 01/02/2015
Davies, Dr Andrew a.davies**[ta]**thampton.ac.uk
CRUK/12/040: IELSG 37 - A randomised, open-label, multicentre, two-arm phase III comparative study assessing the role of involved mediastinal radiotherapy after rituximab containing chemotherapy regimens to patients with newly diagnosed primary mediastinal B-Cell lymphoma (PMBL) University of Southampton 01/05/2013
Preclinical development & CRUKD/12/003: A Phase I frst in human trial of anti-CD19 DI-B4 monoclonal antibody in patients with indolent
Exploratory & preclinical development & CRUKD/16/
Davies, Dr Faith Targeting intracellular protein handling as a strategy for cancer therapy; using Multiple Myeloma as a model Institute of Cancer Research 01/02/2011
Targeting intracellular protein handling as a strategy for cancer therapy; using Multiple Myeloma as a model Institute of Cancer Research 01/10/2011
de Bono, Professor Johann johann.de-bono**[ta]**.ac.uk
CRUKE/12/050: A randomised Phase II study of enzalutamide (MDV3100) in combination with AZD
CRUK/11/029: TO-PARP: Trial of Olaparib in Patients with Advanced Castration Resistant Prostate Cancer (AZ/NCRN) Institute of Cancer Research 01/06/2012
CRUKD/08/
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Identifcation And Molecular Characterisation Of Metastatic Sporadic Castration Resistant Prostate Cancers (mCRPC) With Homologous Recombination DNA Repair Defects That Can Be Targeted By A Synthetic Lethal Strategy Institute of Cancer Research 01/08/2011
de Bruin, Professor Marijn m.debruin**[ta]**n.ac.uk
Making results of smoking cessation trials more useful to policy and practice: Identifying the effective behavioural components of smoking cessation support provided to intervention and control groups by applying innovative methods for evidence
De Piccoli, Dr Giacomo G.de-Piccoli**[ta]**wick.ac.uk
Novel mechanisms through which the S-phase checkpoint pathway preserves genome integrity University of Warwick 01/10/2013
De Santo, Dr Carmela c.desanto**[ta]**m.ac.uk
Investigating the immunosuppressive microenvironment created by Acute Myeloid Leukaemia using invariant Natural Killer T cells as a novel therapeutic approach.University of Birmingham 01/03/2015
de Vocht, Dr Frank Cancer mortality and incidence in the British Rubber industry - a 45 year follow-up University of Bristol 01/11/2013
Dearnaley, Professor David david.dearnaley**[ta]**.ac.uk
An evaluation of biomarkers in hypofractionated and dose escalated prostate cancer radiotherapy: TransCHHiP Study Institute of Cancer Research 01/12/2011
deSouza, Professor Nandita nandita.desouza**[ta]**.ac.uk
Standardization of DWI MRI for quantitative assessment of ovarian cancer and implementation in clinical trials Institute of Cancer Research 01/10/2011
Difey, Dr John Chromosome Replication The Francis Crick Institute 01/10/2012
Dinkova-Kostova, Dr Albena The role of the Keap1/Nrf2 pathway in tumour metabolic adaptation University of Dundee 01/06/2015
Dive, Professor Caroline caroline.dive**[ta]**k.manchester.ac.uk
Assessment of the anti-tumour efcacy and pharmacodynamic effects of combining the Wee1 inhibitor AZD1775 with small cell lung cancer standard of care chemotherapy cisplatin/etoposide or topotecan in unique small cell lung cancer circulating tumour cell derived xenograft models Cancer Research UK Manchester Institute 01/05/2015
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Assessment of the anti-tumour efcacy and pharmacodynamic effects of combining the Wee1 inhibitor AZD1775 with the Hsp90 inhibitor AT
Clinical and Experimental
Dobbie, Miss Fiona fona.dobbie**[ta]**r.ac.uk
Developing social network support to improve smoking cessation outcomes for pregnant women living in disadvantaged areas.University of Stirling 01/10/2014
dos Santos Silva, Professor Isabel isabel.silva**[ta]**tm.ac.uk
Breast tissue composition at young ages and its determinants: a study nested within a British birth cohort London School of Hygiene and Tropical Medicine 01/11/2011
Analysis of the PBAF and INO80 chromatin remodelling complexes and their impact on genome stability University of Sussex 01/01/2014
Downward, Professor Julian julian.downward**[ta]**ck.ac.uk
Novel approaches to targeting RAS oncogene signaling in cancer The Francis Crick Institute 01/11/2012
Dowsett, Professor Mitchell mitch.dowsett**[ta]**.ac.uk
CRUKE/13/031: PALLET: An assessment of the biological and clinical effects of palbociclib with letrozole in the neoadjuvant treatment of ER+ primary breast cancer Institute of Cancer Research 01/07/2014
Integration of 2 week Ki67 with IHC
Drew, Dr Yvette yvette.drew**[ta]**.ac.uk
Preclinical combination studies of imatinib and olaparib in Homologous recombination stratifed relapsed ovarian cancer Newcastle University 01/06/2015
D'Sa, Dr Shirley shirley.dsa**[ta]**h.nhs.uk
CRUK/14/032 IDRIS: Phase III randomised trial of immunomodulatory therapy in high risk solitary bone plasmacytoma University College London 01/08/2015
Dunlop, Professor Malcolm malcolm.dunlop**[ta]**m.ed.ac.uk
Dissecting the genetics of colorectal
Dunning, Dr Alison Genetic Epidemiology of Cancer, Sample Handling, Genotyping and Mutation Detection Core University of Cambridge 01/10/2013
The above is a list of Cancer Research
CRUK/08/037 ARTemis: Avastin Randomised Trial with neo-adjuvant chemotherapy for patients with early HER 2 negative breast
CRUK/13/020: A randomized phase II study evaluating the role of maintenance therapy with cabozantinib vs placebo in High Grade Uterine Sarcoma (HGUS) after stabilization or response to CT following surgery or in metastatic 1st-line treatment (International Rare Cancers Initiative study - IRCI 006) NHS Greater Glasgow and Clyde 01/01/2015
Easton, Professor Douglas Epidemiological study of BRCA1 and BRCA2 mutation carriers (EMBRACE) University of Cambridge 01/02/2014
Genetic Epidemiology of
Eccles, Professor Diana Prospective study of Outcomes in Sporadic versus Hereditary breast
Edmondson, Professor Richard richard.edmondson**[ta]**chester.ac.uk
CRUK/10/056: PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological
CRUK/10/056: Translational research in potentially hormone responsive recurrent/metastatic gynaecological neoplasms - TRANS PARAGON University of Glasgow 01/06/2012
Edmunds, Professor John john.edmunds**[ta]**tm.ac.uk
Predicting the impact of HPV vaccination on cervical cancer: the interaction with screening London School of Hygiene and Tropical Medicine 01/07/2011
Eeles, Professor Rosalind lorna.barakzai**[ta]**.ac.uk
Translational studies in prostate cancer genetics: an oncogenetics programme Institute of Cancer Research 01/10/2014
FULL STUDY International Cancer Genome Consortium: The Prostate Cancer Initiative: a UK-North American-French- Asian-Partnership (ICGC-PROSTATE CANCER) Institute of Cancer Research 01/09/2011
Eisen, Professor Tim tgqe2**[ta]**.ac.uk
CRUK/06/004: SORCE - A phase III randomised controlled study comparing sorafenib with placebo in patients with resected primary renal cell cancer carcinoma at high or intermediate risk of relapse University College London 01/04/2006
The above is a list of Cancer Research
Symptoms associated with cancer in the
Elliott, Dr Martin CRUK/02/013: High Risk Neuroblastoma Study 1 of SIOP - Europe (Extension) University of Birmingham 01/03/2007
Elliott, Professor Tim tje**[ta]**on.ac.uk
Peptide selection in the MHC I antigen processing pathway and its relevance to cancer University of Southampton 01/02/2015
Enver, Professor Tariq t.enver**[ta]**.ac.uk
Characterisation of leukaemic stem cell biology in childhood AML University College London 01/01/2012
Kaposi's sarcoma herpesvirus: The role of latency transcripts in lymphatic endothelial cell biology and
- 項目對接快訊
-
- 最新信息
- 熱門信息
